Efficacy and Safety of a Ketogenic Diet in Type 1 Diabetes
Washington University School of Medicine
58 participants
Aug 12, 2024
INTERVENTIONAL
Conditions
Summary
Despite strong evidence that tight control of blood sugar reduces the risk of diabetes complications, most people with type 1 diabetes do not achieve recommended blood sugar targets. This randomized controlled trial will test whether a very-low- carbohydrate ketogenic diet can effectively and safely improve blood sugar control in adults with type 1 diabetes.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants will consume a very-low-carbohydrate ketogenic diet for 12 weeks.
Participants will consume an American Diabetes Association-recommended standard diet for 12 weeks.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06503809